19,807 Shares in Avantor, Inc. (NYSE:AVTR) Bought by Forum Financial Management LP

Forum Financial Management LP acquired a new stake in Avantor, Inc. (NYSE:AVTR - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 19,807 shares of the company's stock, valued at approximately $417,000.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Louisiana State Employees Retirement System raised its position in Avantor by 0.3% during the 4th quarter. Louisiana State Employees Retirement System now owns 188,900 shares of the company's stock worth $3,980,000 after buying an additional 500 shares during the last quarter. Blue Trust Inc. increased its stake in shares of Avantor by 6.9% during the fourth quarter. Blue Trust Inc. now owns 8,069 shares of the company's stock worth $170,000 after acquiring an additional 522 shares during the period. Pacer Advisors Inc. raised its holdings in Avantor by 0.5% during the fourth quarter. Pacer Advisors Inc. now owns 99,825 shares of the company's stock worth $2,103,000 after purchasing an additional 542 shares in the last quarter. MassMutual Private Wealth & Trust FSB lifted its position in Avantor by 99.5% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company's stock valued at $26,000 after purchasing an additional 625 shares during the period. Finally, Oregon Public Employees Retirement Fund increased its position in Avantor by 0.6% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 138,465 shares of the company's stock worth $2,917,000 after purchasing an additional 765 shares during the period. 95.08% of the stock is owned by hedge funds and other institutional investors.

Avantor Trading Down 16.6 %

NYSE AVTR traded down $2.57 during trading hours on Friday, hitting $12.93. 43,597,894 shares of the company's stock were exchanged, compared to its average volume of 7,146,801. The business's 50 day moving average is $16.02 and its 200-day moving average is $19.79. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.70 and a current ratio of 1.07. Avantor, Inc. has a 12-month low of $12.20 and a 12-month high of $28.00. The firm has a market capitalization of $8.81 billion, a P/E ratio of 12.43, a price-to-earnings-growth ratio of 1.55 and a beta of 1.24.

Avantor (NYSE:AVTR - Get Free Report) last released its earnings results on Friday, April 25th. The company reported $0.23 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.23. The firm had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.61 billion. Avantor had a net margin of 10.49% and a return on equity of 12.17%. During the same period in the previous year, the firm earned $0.22 earnings per share. As a group, analysts anticipate that Avantor, Inc. will post 1.06 EPS for the current fiscal year.

Insider Activity at Avantor

In related news, CAO Steven W. Eck sold 4,907 shares of Avantor stock in a transaction on Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total transaction of $86,019.71. Following the transaction, the chief accounting officer now owns 40,604 shares in the company, valued at approximately $711,788.12. The trade was a 10.78 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP James Bramwell sold 3,758 shares of the stock in a transaction that occurred on Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total transaction of $65,877.74. Following the completion of the sale, the executive vice president now directly owns 87,379 shares of the company's stock, valued at $1,531,753.87. This trade represents a 4.12 % decrease in their position. The disclosure for this sale can be found here. 1.20% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

AVTR has been the topic of a number of recent analyst reports. Stifel Nicolaus dropped their price objective on Avantor from $28.00 to $26.00 and set a "buy" rating on the stock in a report on Monday, February 10th. Morgan Stanley reduced their price target on shares of Avantor from $27.00 to $25.00 and set an "overweight" rating for the company in a research report on Monday, February 10th. Royal Bank of Canada lowered their price target on Avantor from $33.00 to $31.00 and set an "outperform" rating on the stock in a report on Monday, February 10th. Raymond James reissued an "outperform" rating and issued a $24.00 target price (down previously from $26.00) on shares of Avantor in a report on Monday, February 10th. Finally, UBS Group reiterated a "neutral" rating and issued a $25.00 price objective (down from $29.00) on shares of Avantor in a research report on Friday, January 17th. Two equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $24.82.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.